{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:36:06Z","timestamp":1793763366555,"version":"4.6.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001849","name":"Defence Research and Development Organisation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001849","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bmc.2023.117515","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T20:00:10Z","timestamp":1698955210000},"page":"117515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Design, development and bio-evaluation of a novel radio-ligand 99mTc-THQ-DTPA as a sigma 2 receptor specific breast tumor imaging agent"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9589-3846","authenticated-orcid":false,"given":"Vishakha","family":"Chaudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhra","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Wadhwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7335-6508","authenticated-orcid":false,"given":"Ritika","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0523-5998","authenticated-orcid":false,"given":"Divya","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117515_b0005","first-page":"420","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019","volume":"8","author":"Kocarnik","year":"2022","journal-title":"J Am Med Assoc Oncol"},{"key":"#cr-split#-10.1016\/j.bmc.2023.117515_b0010.1","doi-asserted-by":"crossref","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries,CA: a cancer journal for clinicians71","DOI":"10.3322\/caac.21660"},{"key":"#cr-split#-10.1016\/j.bmc.2023.117515_b0010.2","unstructured":"(3) (2021) 209-249,doi: 10.3322\/caac.21660.Epub 2021 Feb 4."},{"key":"10.1016\/j.bmc.2023.117515_b0015","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.22618","article-title":"Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer registry","volume":"109","author":"Bauer","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.bmc.2023.117515_b0020","doi-asserted-by":"crossref","unstructured":"Bianchini, G., Balko, J. M., Mayer, I. A., Sanders, M. E., & Gianni, L., Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease, Nature reviews Clinical oncology13(11) (2016) 674-690,doi:10.1038\/nrclinonc.2016.66 17 May 2016.","DOI":"10.1038\/nrclinonc.2016.66"},{"key":"10.1016\/j.bmc.2023.117515_b0025","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","article-title":"The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmc.2023.117515_b0030","doi-asserted-by":"crossref","unstructured":"Alon, A., Schmidt, H. R., Wood, M. D., Sahn, J. J., Martin, S. F., & Kruse, A. C., Identification of the gene that codes for the \u03c32 receptor,Proceedings of the National Academy of Sciences114(27) (2017) 7160-7165,doi:10.1073\/pnas.1705154114.","DOI":"10.1073\/pnas.1705154114"},{"key":"10.1016\/j.bmc.2023.117515_b0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0922-4106(94)90115-5","article-title":"Rat liver and kidney contain high densities of \u03c31 and \u03c32 receptors: characterization by ligand binding and photoaffinity labelling","volume":"268","author":"Hellewell","year":"1994","journal-title":"Eur J Pharmacol Mol Pharmacol"},{"key":"10.1016\/j.bmc.2023.117515_b0040","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/med.21297","article-title":"Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy","volume":"34","author":"Huang","year":"2014","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmc.2023.117515_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s43440-021-00310-7","article-title":"Sigma receptors and neurological disorders","volume":"73","author":"Piechal","year":"2021","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.bmc.2023.117515_b0050","doi-asserted-by":"crossref","first-page":"8231","DOI":"10.1007\/s13277-015-3552-6","article-title":"RNA interference against TMEM97 inhibits cell proliferation, migration, and invasion in glioma cells","volume":"36","author":"Qiu","year":"2015","journal-title":"Tumor Biol"},{"key":"10.1016\/j.bmc.2023.117515_b0055","doi-asserted-by":"crossref","unstructured":"D Banister, S., &Kassiou, M., The therapeutic potential of sigma (\u03c3) receptors for the treatment of central nervous system diseases: evaluation of the evidence, Current Pharm Des 18(7) (2012) 884-901, doi: 10.2174\/138161212799436539.","DOI":"10.2174\/138161212799436539"},{"key":"10.1016\/j.bmc.2023.117515_b0060","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/jnc.13917","article-title":"Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease","volume":"140","author":"Yi","year":"2017","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmc.2023.117515_b0065","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.bbrc.2015.09.157","article-title":"The sigma-2 receptor as a therapeutic target for drug delivery in triple negative breast cancer","volume":"467","author":"Makvandi","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2023.117515_b0070","first-page":"156","article-title":"\u03c32 receptors as potential biomarkers of proliferation in breast cancer","volume":"57","author":"Mach","year":"1997","journal-title":"Cancer research"},{"key":"10.1016\/j.bmc.2023.117515_b0075","doi-asserted-by":"crossref","unstructured":"Wheeler, K. T., & Mach, R. H. Jinbin Xu, Zhude Tu, Lynne A. Jones, SuwannaVangveravong., [3H] N-[4-(3, 4-dihydro-6, 7-dimethoxyisoquinolin-2 (1H)-yl) butyl]-2-methoxy-5-methylbenzamide: a novel sigma-2 receptor probe, Europ J Pharmacol 525 (2005) 8-17,doi:10.1016\/j.ejphar.2005.09.063.","DOI":"10.1016\/j.ejphar.2005.09.063"},{"key":"10.1016\/j.bmc.2023.117515_b0080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejmech.2017.11.016","article-title":"Synthesis and pharmacological evaluation of 6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as sigma-2 receptor ligands","volume":"147","author":"Sun","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117515_b0085","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1039\/C3OB42254B","article-title":"Synthesis and in vitro evaluation of tetrahydroisoquinolines with pendent aromatics as sigma-2 (\u03c3 2) selective ligands","volume":"12","author":"Ashford","year":"2014","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2023.117515_b0090","doi-asserted-by":"crossref","first-page":"e74188","DOI":"10.1371\/journal.pone.0074188","article-title":"Quantitative receptor-based imaging of tumor proliferation with the sigma-2 ligand [18F] ISO-1","volume":"8","author":"Shoghi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2023.117515_b0095","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2967\/jnumed.112.111948","article-title":"Assessment of cellular proliferation in tumors by PET using 18F-ISO-1","volume":"54","author":"Dehdashti","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmc.2023.117515_b0100","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.apradiso.2010.06.004","article-title":"Radiosynthesis and biological evaluation of a promising \u03c32-receptor ligand radiolabeledwith fluorine-18 or iodine-125 as a PET\/SPECT probe for imaging breast cancer","volume":"68","author":"Tu","year":"2010","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.bmc.2023.117515_b0105","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1021\/jm301545c","article-title":"The \u03c32 receptor: a novel protein for the imaging and treatment of cancer","volume":"56","author":"Mach","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117515_b0115","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1021\/bc9700087","article-title":"99mTc-labeled \u03c3-receptor-binding complex: Synthesis, characterization, and specific binding to human ductal breast carcinoma (T47D) cells","volume":"8","author":"John","year":"1997","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.bmc.2023.117515_b0120","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1021\/acs.jmedchem.5b01378","article-title":"99mTc-cyclopentadienyl tricarbonyl chelate-labeled compounds as selective sigma-2 receptor ligands for tumor imaging","volume":"59","author":"Li","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117515_b0125","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0969-8051(01)00234-7","article-title":"Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent","volume":"28","author":"Choi","year":"2001","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.bmc.2023.117515_b0130","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1016\/j.bmcl.2012.08.083","article-title":"Synthesis and biological evaluation of a novel 99mTc cyclopentadienyl tricarbonyl complex ([(Cp-R) 99mTc (CO) 3]) for sigma-2 receptor tumor imaging","volume":"22","author":"Chen","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117515_b0110","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/jlcr.3531","article-title":"Technetium99m radiochemistry for pharmaceutical applications","volume":"60","author":"Papagiannopoulou","year":"2017","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.bmc.2023.117515_b0135","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2023.117515_b0140","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2023.117515_b0145","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41586-021-04175-x","article-title":"Structures of the \u03c32 receptor enable docking for bioactive ligand discovery","volume":"600","author":"Alon","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117515_b0150","doi-asserted-by":"crossref","first-page":"15032","DOI":"10.1039\/C8NJ00089A","article-title":"Design, physico-chemical and pre-clinical evaluation of a homo-bivalent 99m Tc-(BTZ) 2 DTPA radioligand for targeting dimeric 5-HT 1A\/5-HT 7 receptors","volume":"42","author":"Jha","year":"2018","journal-title":"New J Chem"},{"key":"10.1016\/j.bmc.2023.117515_b0155","article-title":"5-HT1A targeting PARCEST agent DO3AM-MPP with potential for receptor imaging: Synthesis, physico-chemical and MR studies","volume":"106","author":"Chaturvedi","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2023.117515_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/0471141755.ph0134s71","article-title":"Sigma receptor binding assays","volume":"71","author":"Chu","year":"2015","journal-title":"Current Protoc Pharmacol"},{"key":"10.1016\/j.bmc.2023.117515_b0165","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2015.05.026","article-title":"Characterization of pulmonary sigma receptors by radioligand binding","volume":"762","author":"Lever","year":"2015","journal-title":"Eur J Pharmacol"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:23:18Z","timestamp":1760836998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623003632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":34,"alternative-id":["S0968089623003632"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117515","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, development and bio-evaluation of a novel radio-ligand 99mTc-THQ-DTPA as a sigma 2 receptor specific breast tumor imaging agent","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117515"}}